<SEC-DOCUMENT>0001437749-22-001821.txt : 20220128
<SEC-HEADER>0001437749-22-001821.hdr.sgml : 20220128
<ACCEPTANCE-DATETIME>20220128080016
ACCESSION NUMBER:		0001437749-22-001821
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20220124
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220128
DATE AS OF CHANGE:		20220128

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33678
		FILM NUMBER:		22565350

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>nby20220118_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:nby="http://www.nby.com/20220124"><head>
	<title>nby20220118_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 1/28/2022 4:52:33 AM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20228K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20228K" name="dei:EntityCentralIndexKey">0001389545</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="nby-20220124.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20228K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001389545</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-24</xbrli:startDate>
<xbrli:endDate>2022-01-24</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>WASHINGTON, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20228K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Pursuant to Section 13 or 15(d) of the</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Securities Exchange Act of 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Date of earliest event reported: </b><ix:nonNumeric contextRef="d20228K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">January 24, 2022</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityRegistrantName">NovaBay Pharmaceuticals, Inc.</ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Exact Name of Registrant as Specified in Charter)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:16.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:16.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityFileNumber">001-33678</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:16.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityTaxIdentificationNumber">68-0454536</ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(State or Other Jurisdiction</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>of Incorporation)</b></div>
			</td>
			<td style="vertical-align:top;width:16.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Commission File Number)</b></div>
			</td>
			<td style="vertical-align:top;width:16.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(I.R.S. Employer</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Identification No.)</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressAddressLine1">2000 Powell Street, Suite 1150</ix:nonNumeric>, <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressCityOrTown">Emeryville</ix:nonNumeric>, <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric> <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressPostalZipCode">94608</ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Address of Principal Executive Offices) (Zip Code)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(<ix:nonNumeric contextRef="d20228K" name="dei:CityAreaCode">510</ix:nonNumeric>) <ix:nonNumeric contextRef="d20228K" name="dei:LocalPhoneNumber">899-8800</ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Registrant</b>&#8217;<b>s telephone number, including area code)</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 4%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align: top; width: 96%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 4%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align: top; width: 96%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 4%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align: top; width: 96%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 4%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align: top; width: 96%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:17.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">Title of Each Class</span></b></div>
			</td>
			<td style="vertical-align:bottom;width:12.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">Trading Symbol(s)</span></b></div>
			</td>
			<td style="vertical-align:bottom;width:17.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">Name of Each Exchange On Which Registered</span></b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:17.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric>, par value $0.01 per share</div>
			</td>
			<td style="vertical-align:top;width:12.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:TradingSymbol">NBY</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:17.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric> American</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tbody><tr>
			<td style="width: 100%;">Emerging growth company <ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:-72pt;"><b>Item 1.01</b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Entry into a Material Definitive Agreement</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NovaBay Pharmaceuticals, Inc. (the &#8220;Company&#8221;) currently leases approximately 7,675 rentable square feet of real property as its principal corporate headquarters, located at 2000 Powell Street, Suite 1150, Emeryville, California from KBSIII Towers at Emeryville, LLC (the &#8220;Landlord&#8221;) under that certain Office Lease, dated August 24, 2016 (the &#8220;Lease&#8221;).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On January 24, 2022, the Company and the Landlord entered into a First Amendment to the Office Lease (the &#8220;Lease Amendment&#8221;), effective January 19, 2022, to extend the term of the Lease, currently set to expire on February 28, 2022, for sixty-five (65) months commencing as of March 1, 2022 and expiring on July 31, 2027, unless sooner terminated in accordance with the terms of the Lease, as amended by the Lease Amendment (the &#8220;Extended Term&#8221;).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The effective monthly base rental rate for the first twelve (12) months of the Extended Term is $4.70 per square foot ($432,870.00 annually), and increases approximately three percent (3%) every twelve (12) months thereafter beginning with the 13th month of the Extended Term with a maximum monthly rental rate of $4.45 per square foot ($501,815.04 annually) for the final five months of the Extended Term. Notwithstanding the increase base rental rate, the Landlord has agreed to abate the Company&#8217;s obligation to pay base rent during five months of the Extended Term (March 2022, 2023, 2024, 2025 and 2026) and to provide the Company with an allowance of up to $25.00 per rentable square foot ($191,875.00 total) for certain design and interior improvements.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The foregoing description of the terms of the Lease and the Lease Amendment do not purport to be complete and are subject to, and are qualified in their entirety by, reference to the Lease and the Lease Amendment, which are filed herewith as Exhibits 10.1 and 10.2, respectively, and are incorporated by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 72pt;text-indent:-72pt;"><b>Item 5.02</b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">(b) and (d)&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On January 27, 2022, the Board of Directors (the &#8220;Board&#8221;) of the Company increased the size of the Board to eight (8) directors and appointed Dr. Audrey Kunin and Ms. Julie Garlikov to fill these two new vacancies on the Board resulting from the increased Board size further enhancing the Board&#8217;s experience and diversity.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Effective January 27, 2022, the Board appointed Dr. Kunin to serve as a Class I director of the Company to serve until the Company&#8217;s 2023 Annual Meeting of Stockholders, subject to her prior death, resignation or removal from office as provided by law.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Dr. Kunin, age 62, is the Company&#8217;s Chief Product Officer. Dr. Kunin co-founded DERMAdoctor, LLC (&#8220;DERMAdoctor&#8221;), the Company&#8217;s wholly-owned subsidiary, and previously served as the Chief Creative Officer of DERMAdoctor since March 2018 and as the Chief Executive Officer and its predecessor beginning in 1998. Dr. Kunin graduated from Ohio State University in December 1980 and received her M.D. at the Medical College of Ohio in June 1985. She received her postgraduate training in Dermatology at the Medical College of Virginia after serving as Chief Resident in July 1989. She is a fellow of the American Academy of Dermatology and formerly served as an Assistant Clinical Instructor of Dermatology at the University of Kansas School of Medicine.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Dr. Kunin is party to an employment agreement with the Company, which is described in the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 12, 2021 (the &#8220;DERMAdoctor Form 8-K&#8221;) and such description is incorporated by reference herein. Separately, the Company entered into a side letter with Dr. Kunin to provide for Dr. Kunin&#8217;s appointment to NovaBay&#8217;s Board of Directors as a Class I director as soon as reasonably practicable following the closing of the DERMAdoctor transaction, which is further described in the DERMAdoctor Form 8-K and such description is incorporated by reference herein. The incorporated description of the employment agreement and side letter with Dr. Kunin does not purport to be complete and is qualified in its entirety by reference to the full text of the employment agreement and the side letter, which are attached hereto as Exhibits 10.3&#xa0;and 10.4, respectively, and incorporated by reference herein. Other than as described above, there is no other arrangement or understanding between Dr. Kunin and any other person pursuant to which she was appointed as a director of the Company. As an employee director of the Company, Dr. Kunin will not participate in the Company&#8217;s Non-Employee Director Compensation Program or serve on any of the Board's committees.&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Effective January 27, 2022, the Board also appointed Ms. Garlikov to serve as an independent Class II director of the Company to serve until the Company&#8217;s 2024 Annual Meeting of Stockholders, subject to her prior death, resignation or removal from office as provided by law.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Ms. Garlikov, age 51, is the Vice President of Marketing of GRAIL, LLC, a biotechnology and pharmaceutical company. She has served in this position since November 2020.&#xa0; Ms. Garlikov has over 25 years of experience in marketing, which includes serving as the Chief Marketing Officer at NewAge and Shaklee, as well as senior marketing positions at Rodan &amp; Fields, Obagi Medical and Nuvesse Skin Therapies. Julie is a classically trained CPG marketer who gained her consumer experience at Procter &amp; Gamble, Johnson &amp; Johnson and PepsiCo. She has deep expertise in health, beauty and eyecare products, as well as in consumer advertising and digital demand generation.&#xa0; Ms. Garlikov has a Bachelor&#8217;s degree from the University of California, Berkley and a Master&#8217;s degree in Business Administration from Columbia University.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">There is no&#xa0;other arrangement or understanding between Ms. Garlikov<b> </b>and any other person pursuant to which she was appointed as a director of the Company. In connection with her service,<b> </b>Ms. Garlikov&#xa0;will participate in the Company&#8217;s Non-Employee Director Compensation Program.&#xa0;Ms. Garlikov will not serve on any of the Board's committees at this time.&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Additionally, on January 27, 2022, Xinzhou (Paul) Li informed the Board that he will resign as a member of the Company&#8217;s Board, with such resignation to be effective immediately. Mr. Li did not resign as a result of any disagreements with the Company.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Effective January 27, 2022, upon the resignation of Mr. Li, the Board appointed Mr. Yongxiang (Sean) Zheng&#xa0;to fill the vacancy on the Board resulting from the resignation of Mr. Li. Mr. Sean Zheng will take Mr. Li&#8217;s place as a Class II director to serve until the Company&#8217;s 2024 Annual Meeting of Stockholders, subject to his prior death, resignation or removal from office as provided by law.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">Mr. Sean Zheng, age 52, is the Chief Executive Officer of Q3 Medical Devices (Shanghai) Co. Ltd. (&#8220;Q3 Medical&#8221;). Prior to joining Q3 Medical, Mr. Sean Zheng held several Chief Executive positions, including MD of Boill Fund Management (HK) Co., Ltd. and MD and CEO of Sprott- Zijin Mining Fund, a JV fund between Zijin Mining Group and Sprott Asset Management LP.&#xa0; Mr. Sean Zheng has more than 27 years&#8217; experience in mergers and acquisitions, fund management, and import/export business.&#xa0; Mr. Sean Zheng has been a CFA chartered holder since 2006 and graduated from Renmin University of China in 1992. He holds a B.S degree in Commodity Science. He received his MBA from the University of New South Wales in 2002, and he earned a masters degree of EMBA from China Europe International Business School (CEIBS) in 2010.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">Mr. Sean Zheng was recommended as a director by certain&#xa0;large Chinese stockholders of the Company. There is no&#xa0;other arrangement or understanding between Mr. Sean&#xa0;Zheng&#xa0;and any other person pursuant to which he was appointed as a director of the Company. In connection with his service, Mr. Sean&#xa0;Zheng&#xa0;will participate in the Company&#8217;s Non-Employee Director Compensation Program.&#xa0;Mr. Sean Zheng will not serve on any of the Board's committees at this time.&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">(e)</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On January 26, 2022, the Compensation Committee of the Board approved, and the Company and Justin M. Hall, the Chief Executive Officer and General Counsel of the Company, entered into, a First Amendment, effective as of December 31, 2021 (the &#8220;Amendment&#8221;), to Mr. Hall&#8217;s Executive Employment Agreement, dated January 31, 2020 (the &#8220;Employment Agreement&#8221;), to extend the duration of the term of his Employment Agreement, which expired on December 31, 2021, to provide for a term ending December 31, 2023 (unless terminated earlier in accordance with the terms of the Employment Agreement).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The foregoing description of the terms of the Employment Agreement and the Amendment do not purport to be complete and are subject to, and are qualified in their entirety by, reference to the Employment Agreement and the Amendment, which are filed herewith as Exhibits 10.5&#xa0;and 10.6, respectively, and are incorporated by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 9.01</b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Financial Statements and Exhibits</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(d)&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<span style="text-decoration: underline;">Exhibits</span></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Exhibit No.</div>
			</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 86%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Description</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 11%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">10.1</div>
			</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 86%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774916038133/ex10-1.htm" style="-sec-extract:exhibit;">Office Lease by and between the Company and KBSIII Towers at Emeryville, LLC, dated August 24, 2016 (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 26, 2016)</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 11%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">10.2</div>
			</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 86%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_325548.htm" style="-sec-extract:exhibit;">First Amendment to Office Lease by and between the Company and KBSIII Towers at Emeryville, LLC, dated January 24, 2022</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 11%;">10.3+</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 86%;"><a href="http://www.sec.gov/Archives/edgar/data/0001389545/000143774921026234/ex_306146.htm" style="-sec-extract:exhibit;">Executive Employment Agreement with Dr. Audrey Kunin, dated November 5, 2021 (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 12, 2021)</a></td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 11%;">10.4+</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 86%;"><a href=" http://www.sec.gov/Archives/edgar/data/0001389545/000143774921026234/ex_306148.htm" style="-sec-extract:exhibit;">Side Letter with Dr. Audrey Kunin, dated November 5, 2021 (incorporated by reference to Exhibit 10.3 of the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 12, 2021)</a></td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 11%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">10.5+</div>
			</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 86%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774920001861/ex_171553.htm" style="-sec-extract:exhibit;">Executive Employment Agreement with Justin M. Hall, dated January 31, 2020 (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 6, 2020)</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 11%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">10.6+</div>
			</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 86%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_325549.htm" style="-sec-extract:exhibit;">First Amendment to Executive Employment Agreement with Justin M. Hall, dated January 26, 2022</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 11%;">99.1</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 86%;"><a href="ex_329098.htm" style="-sec-extract:exhibit;">Press Release, dated January 28, 2022</a></td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 11%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">104</div>
			</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 86%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align: top; width: 14%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">+ Indicates a management contract or compensatory plan or arrangement</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tbody><tr>
			<td valign="top" style="width: 50%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
			<td colspan="2" valign="top" style="width: 38%; ">
			<div style="margin-top: 0; margin-bottom: 0;"><b>NovaBay Pharmaceuticals, Inc.</b></div>
			</td>
			<td valign="top" style="width: 12%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
		</tr>
		<tr>
			<td valign="top" style="width: 50%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
			<td valign="top" style="width: 3%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
			<td valign="top" style="width: 35%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
			<td valign="top" style="width: 12%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
		</tr>
		<tr>
			<td valign="top" style="width: 50%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
			<td valign="top" style="width: 3%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
			<td align="left" valign="bottom" style="nowrap: nowrap; width: 35%;">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
			<td valign="top" style="width: 12%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
		</tr>
		<tr>
			<td align="left" style="width: 50%; text-align: left;" valign="top">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
			<td style="width: 3%; text-align: left" valign="top">
			<div style="margin-top: 0; margin-bottom: 0;"><span style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </span></div>
			</td>
			<td align="left" style="nowrap: nowrap; width: 35%; BORDER-BOTTOM: #000000 1px solid" valign="top">
			<div style="margin-top: 0; margin-bottom: 0;"><span style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/ &#xa0;</span>Justin M. Hall</div>
			</td>
			<td valign="top" style="width: 12%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
		</tr>
		<tr>
			<td valign="top" style="width: 50%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
			<td valign="top" style="width: 3%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
			<td valign="top" style="width: 35%; ">
			<div style="margin-top: 0; margin-bottom: 0;">Justin M. Hall</div>
			</td>
			<td valign="top" style="width: 12%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
		</tr>
		<tr>
			<td valign="top" style="width: 50%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
			<td valign="top" style="width: 3%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
			<td valign="top" style="width: 35%; ">
			<div style="margin-top: 0; margin-bottom: 0;">Chief Executive Officer and General Counsel</div>
			</td>
			<td valign="top" style="width: 12%; ">
			<div style="margin-top: 0; margin-bottom: 0;"></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dated: January 28, 2022</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>ex_325548.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html><head>
	<title>ex_325548.htm</title>

	<!-- Generated by ThunderDome Portal - 1/28/2022 3:16:28 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin-bottom: 0px; margin-top: 0px; text-align: right;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.2</b></font></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>FIRST AMENDMENT TO OFFICE LEASE</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This FIRST AMENDMENT TO OFFICE LEASE (this &#8220;<b>Amendment</b>&#8221;), dated as of January 19, 2022 (&#8220;<b>Effective Date</b>&#8221;), is entered into by and between KBSIII TOWERS AT EMERYVILLE, LLC, a Delaware limited liability company (&#8220;<b>Landlord</b>&#8221;), and NOVABAY PHARMACEUTICALS, INC., a&nbsp;Delaware corporation (&#8220;<b>Tenant</b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>R</u> <u>E</u> <u>C</u> <u>I</u> <u>T</u> <u>A</u> <u>L</u> <u>S</u>:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to that certain Office Lease dated August 24, 2016 (the &#8220;<b>Lease</b>&#8221;), Tenant currently leases from Landlord those certain premises commonly known as Suite 1150 (the &#8220;<b>Premises</b>&#8221;) containing approximately 7,675 rentable square feet (as remeasured below), located at 2000 Powell Street, Emeryville, California (the &#8220;<b>Building</b>&#8221;), which is part of the Towers Emeryville (the &#8220;<b>Project</b>&#8221;), as more particularly described in the Lease.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capitalized terms not defined herein have the meanings given to such terms in the Lease.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Lease Term is scheduled to expire by its terms on February 28, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The parties desire to amend the Lease in order to, among other things, extend the Lease Term, and further amend the Lease, pursuant to the terms and conditions set forth below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>A</u> <u>G</u> <u>R</u> <u>E</u> <u>E</u> <u>M</u> <u>E</u> <u>N</u> <u>T</u>:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NOW, THEREFORE, in consideration of the foregoing Recitals, the mutual covenants and agreements contained in this Amendment and other good and valuable consideration, the receipt and sufficiency of such are hereby acknowledged, Landlord and Tenant hereby agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Extended Term</u>. The Lease Term is hereby extended for sixty-five (65) months (the &#8220;<b>Extended Term</b>&#8221;) commencing as of March 1, 2022 (the &#8220;<b>Extended Term Commencement Date</b>&#8221;), and expiring on July 31, 2027, unless sooner terminated in accordance with the terms of the Lease, as amended hereby (the &#8220;<b>Amended Lease</b>&#8221;). No such extension shall operate to release Tenant from liability for any amounts owed or defaults which exist under the Lease prior to the Extended Term Commencement Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Base Rent</u>. Prior to the Extended Term Commencement Date, Tenant shall continue to pay monthly Base Rent pursuant to the terms of the Lease. Commencing as of the Extended Term Commencement Date and continuing for the duration of the Extended Term, Tenant shall pay monthly Base Rent for the Premises in accordance with the following schedule:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 80%; margin-left: 10%; margin-right: 10%;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Lease Months</b></p>
			</td>
			<td style="border-color: rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: top; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Monthly Base Rent</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/1/2022 - 2/28/2023</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$36,072.50</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/1/2023 - 2/29/2024</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$37,154.68</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/1/2024 - 2/28/2025</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$38,269.32</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/1/2025 - 2/28/2026</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$39,417.40</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/1/2026 - 2/28/2027</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$40,599.92</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/1/2027 - 7/31/2027</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50.9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">$41,817.92</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">PAGE&nbsp; 1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Abated Amount</u>. Notwithstanding the foregoing schedule, provided Tenant is not in default under the Amended Lease beyond any applicable notice and cure period, Landlord hereby agrees to abate Tenant&#8217;s obligation to pay the monthly Base Rent during the five (5) calendar months of March 2022, March 2023, March 2024, March 2025, and March 2026 (such aggregate amount of abated monthly Base Rent being hereinafter collectively referred to as the &#8220;<b>Abated Amount</b>&#8221;). During such abatement months, Tenant will still be responsible for the payment of all other monetary obligations under the Amended Lease, including, without limitation, Direct Expenses. Tenant acknowledges that any default by Tenant beyond applicable notice and cure periods will cause Landlord to incur costs not contemplated hereunder, the exact amount of such costs being extremely difficult and impracticable to ascertain. Therefore, should Tenant at any time be in default beyond applicable notice and cure periods, then in addition to all of Landlord&#8217;s other rights and remedies, the total unamortized sum of the Abated Amount (amortized on a straight line basis over the Extended Term) so conditionally excused shall become immediately due and payable by Tenant to Landlord; provided, however, Tenant acknowledges and agrees that nothing in this subsection is intended to limit any other remedies available to Landlord at law or in equity under applicable law (including, without limitation, the remedies under Civil Code Section 1951.2 and/or 1951.4 and any successor statutes or similar laws), in the event Tenant defaults under the Amended Lease beyond any applicable notice and cure period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Tenant Improvements</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; Landlord shall provide to Tenant an allowance of up to $25.00 per rentable square foot of the Premises (i.e., up to $191,875.00, based on the Premises consisting of approximately 7,675 rentable square feet, hereinafter referred to as the &#8220;<b>Allowance</b>&#8221;) to be used by Tenant to design and complete interior improvements to refurbish the Premises (the &#8220;<b>Tenant Improvements</b>&#8221;) in accordance with and subject to the terms and conditions of Section 8 of the Lease with respect to Alterations, including, without limitation, the requirement that Tenant obtain Landlord&#8217;s prior written approval for the Tenant Improvements; provided, however, Tenant need not obtain Landlord&#8217;s approval for any portion of the Tenant Improvements which satisfies the conditions set forth in the last sentence of Section 8.1 of the Lease.&nbsp; Landlord shall reimburse the Allowance after the completion of the Tenant Improvements and within thirty (30) days after Landlord&#8217;s receipt of (i) paid invoices from all of the contractors and/or subcontractors (&#8220;<b>Tenant Contractors</b>&#8221;) for labor rendered and materials delivered to the Premises, (ii) executed unconditional mechanic&#8217;s lien releases from all of the Tenant Contractors to whom payment is included in the Allowance, and (iii) all other information reasonably requested by Landlord.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Allowance is applicable only to the Tenant Improvements, and shall not be used for any other purpose, such as, but not limited to, the purchase or installation of furniture, trade fixtures, or personal property.&nbsp; If all or any portion of the Allowance shall not be used by December 31, 2022 (&#8220;<b>Outside Date</b>&#8221;), Landlord shall be entitled to the savings and Tenant shall receive no credit therefor.&nbsp; Notwithstanding anything in this Amendment to the contrary, Landlord shall not be obligated to disburse any portion of the Allowance during the continuance of an uncured default under the Amended Lease.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Notwithstanding the foregoing, Tenant shall have the right to apply an unused portion of the Allowance in the amount of up to $16.00 per rentable square foot of the Premises (i.e., up to $122,800.00, based on the Premises consisting of approximately 7,675 rentable square feet) as a credit against Base Rent next coming due under the Amended Lease, provided that Tenant submits to Landlord written notice of such election and designates a credit against Base Rent to be applied prior to the Outside Date. &nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">PAGE&nbsp; 2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Condition of the Premises</u>. Tenant acknowledges that it is presently in possession of the Premises and is fully aware of the condition of the Premises. Tenant acknowledges that except as expressly provided above, Landlord shall not be obligated to refurbish or improve the Premises in any manner whatsoever or to otherwise provide funds for the improvement of the Premises in conjunction with this Amendment, and Tenant hereby accepts the Premises &#8220;AS-IS&#8221;. Tenant further acknowledges that except as expressly provided in the Lease or this Amendment, neither Landlord nor any agent of Landlord has made any representation or warranty regarding the condition of the Premises, the improvements, refurbishments, or alterations therein, or the Building or the Project or with respect to the functionality thereof or the suitability of any of the foregoing for the conduct of Tenant&#8217;s business and that all representations and warranties of Landlord, if any, are as set forth in the Lease and this Amendment. Pursuant to Section 1938 of the California Civil Code, Landlord hereby advises Tenant that as of the date of this Amendment neither the Premises, nor the Building, nor the Project has undergone inspection by a Certified Access Specialist. Further, pursuant to Section 1938 of the California Civil Code, Landlord notifies Tenant of the following: &#8220;A Certified Access Specialist (CASp) can inspect the subject premises and determine whether the subject premises comply with all of the applicable construction-related accessibility standards under state law. Although state law does not require a CASp inspection of the subject premises, the commercial property owner or lessor may not prohibit the lessee or tenant from obtaining a CASp inspection of the subject premises for the occupancy or potential occupancy of the lessee or tenant, if requested by the lessee or tenant. The parties shall mutually agree on the arrangements for the time and manner of the CASp inspection, the payment of the fee for the CASp inspection, and the cost of making any repairs necessary to correct violations of construction-related accessibility standards within the premises.&#8221; Therefore and notwithstanding anything to the contrary contained in the Amended Lease, Landlord and Tenant agree that (a) Tenant may, at its option and at its sole cost, cause a CASp to inspect the Premises and determine whether the Premises complies with all of the applicable construction-related accessibility standards under California law, (b) the parties shall mutually coordinate and reasonably approve of the timing of any such CASp inspection so that Landlord may, at its option, have a representative present during such inspection, and (c) Tenant shall be solely responsible for the cost of any repairs necessary to correct violations of construction-related accessibility standards within the Premises, the Building, or the Project identified by any such CASp inspection. Tenant shall reimburse Landlord upon demand, as Additional Rent, for any cost to Landlord of performing such alterations and repairs; provided, however, unless such repair or alterations relate solely to other alterations to the Premises which Tenant is obligated to, or elects to, remove upon the expiration or earlier termination of the Amended Lease (in which case Tenant shall simultaneously also remove any CASp-identified alterations and repairs), Tenant shall have no obligation to remove any repairs or alterations made pursuant to a CASp inspection under this Section.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Remeasurement; Direct Expenses</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The parties acknowledge that the Project, including the Building and the Premises, has been remeasured, and for all purposes under the Amended Lease, (i) the Project shall be deemed to consist of 816,090 rentable square feet, (ii) the Building shall be deemed to consist of 361,274 rentable square feet, and (iii) the Premises shall be deemed to consist of 7,675 rentable square feet.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commencing as of the Effective Date and continuing for the duration of the Extended Term, (i) Tenant&#8217;s Share of Direct Expenses shall be 2.12% and (ii) the Base Year shall be adjusted to the calendar year 2022. For the avoidance of doubt, the foregoing computation means Tenant shall have no liability for Tenant&#8217;s Share of Direct Expenses from and after the Effective Date until January 1, 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant acknowledges that: &nbsp;(i) the Towers Emeryville project is separately owned by Landlord and a third party, but is currently operated and managed as a single project, and (ii) Landlord shall have the right, from time to time, to equitably allocate some or all of the Direct Expenses among different tenants, buildings and/or premises, including, without limitation, retail and office areas (the &#8220;<b>Cost Pools</b>&#8221;), in Landlord&#8217;s reasonable discretion.&nbsp; Such Cost Pools may include, for example, the buildings owned by Landlord but not buildings owned by other parties.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Parking</u>. During the Extended Term, Tenant shall continue to be entitled to use up to a maximum of twenty (20) unreserved parking spaces and three (3) reserved parking spaces (such parking spaces are in lieu of, and not in addition to, any parking spaces as to which Tenant was previously granted rights under the Lease). Tenant shall pay Landlord&#8217;s prevailing parking charges, as the same may be adjusted by Landlord from time to time, currently at the rate of $120.00 per unreserved stall per month and $150.00 per reserved stall per month. Tenant&#8217;s use of all such parking shall otherwise be subject to the terms and provisions of the Amended Lease.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">PAGE&nbsp; 3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Extension Option</u>. Tenant shall continue to have one (1) Extension Option of five (5) years, subject to the terms and conditions of Rider No. 1 to Lease. Landlord and Tenant hereby acknowledge and agree that any other provisions of the Lease providing for an extension or renewal of the Lease Term are hereby deleted in their entirety and Tenant has no other options to extend or renew the Extended Term of the Amended Lease.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Letter of Credit</u>. No additional Letter of Credit or Security Deposit shall be required in connection with this Amendment. Concurrently with the execution of this Amendment, Tenant shall deliver a renewal of the existing Letter of Credit in the amount of $323,658.50, which shall update the Final LC Expiration Date to November 28, 2027.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>After-Hours HVAC</u>. For informational purposes, the current after-hours usage charge for the Building is $72.00 per hour.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Landlord</u><u>&#8217;</u><u>s Addresses</u>. Landlord&#8217;s addresses for notices and payment of Rent are hereby amended as follows:</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">Landlord&#8217;s Notice Address:</td>
			<td style="width: 50%;">KBSIII Towers At Emeryville, LLC</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">c/o KBS Capital Advisors, LLC</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">800 Newport Center Drive, Suite 700</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">800 Newport Center Drive, Suite 700</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">Newport Beach, CA 92660</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">Attn: General Counsel</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">With a copy to:</td>
			<td style="width: 50%;">KBSIII Towers At Emeryville, LLC</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">c/o KBS Capital Advisors, LLC</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">800 Newport Center Drive, Suite 700</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">Newport Beach, CA 92660</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">Attn: Brent Carroll, Asset Manager</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">Landlord&#8217;s Address for Payment</td>
			<td style="width: 50%;">KBSIII Towers At Emeryville, LLC</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">of Rent:</td>
			<td style="width: 50%;">P.O. Box 740905</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">Los Angeles, CA 90074-0905</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">For payment of Parking Charges:</td>
			<td style="width: 50%;">LAZ Parking</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">2000 Powell Street, Suite 100</td>
		</tr>
		<tr>
			<td style="width: 11%;">&nbsp;</td>
			<td style="width: 39%;">&nbsp;</td>
			<td style="width: 50%;">Emeryville, CA 94608</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Representations and Warranties</u>. Tenant hereby represents, warrants, and agrees that, to Tenant&#8217;s actual knowledge: (a)&nbsp;there exists no breach, default, or event of default by Landlord under the Lease, or any event or condition which, with notice or passage of time or both, would constitute a breach, default, or event of default by Landlord under the Lease; (b) the Lease continues to be a legal, valid, and binding agreement and obligation of Tenant; and (c) Tenant has no current offset or defense to its performance or obligations under the Lease. Landlord hereby represents, warrants, and agrees that, to Landlord&#8217;s actual knowledge: (a)&nbsp;there exists no breach, default, or event of default by Tenant under the Lease, or any event or condition which, with notice or passage of time or both, would constitute a breach, default, or event of default by Tenant under the Lease; (b) the Lease continues to be a legal, valid, and binding agreement and obligation of Landlord; and (c) Landlord has no current offset or defense to its performance or obligations under the Lease.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Authority</u>. Each signatory of this Amendment on behalf of Tenant represents hereby that he or she has the authority to execute and deliver the same on behalf of the party hereto for which such signatory is acting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Successors and Assigns</u>. This Amendment shall extend to, be binding upon, and inure to the benefit of, the respective successors and permitted assigns and beneficiaries of the parties hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">PAGE&nbsp; 4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Broker</u>. Tenant represents and warrants to Landlord that, with the exception of Cushman &amp; Wakefield, representing Landlord, and Newmark, representing Tenant, it is not aware of any brokers, agents or finders who may claim a fee or commission in connection with the consummation of the transactions contemplated by this Amendment. If any claims for brokers&#8217; or finders&#8217; fees in connection with the transactions contemplated by this Amendment arise, then Tenant agrees to indemnify, protect, hold harmless and defend Landlord (with counsel reasonably satisfactory to Landlord) from and against any such claims if they shall be based upon any statement, representation or agreement made by Tenant.<b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">16.&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; <u>No Other Modification</u>. Landlord and Tenant agree that except as otherwise specifically modified in this Amendment, the Lease has not been modified, supplemented, amended, or otherwise changed in any way and the Lease remains in full force and effect between the parties hereto as modified by this Amendment. To the extent of any inconsistency between the terms and conditions of the Lease and the terms and conditions of this Amendment, the terms and conditions of this Amendment shall apply and govern the parties. This Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which, together, shall constitute one and the same instrument.<b> </b>For purposes of this Amendment, signatures by facsimile or electronic PDF shall be binding to the same extent as original signatures.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[NO FURTHER TEXT ON THIS PAGE; SIGNATURES ON FOLLOWING PAGE]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">PAGE&nbsp; 5</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IN WITNESS WHEREOF, the parties have executed this Amendment as of the date set forth above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Tenant:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">NOVABAY PHARMACEUTICALS, INC.,</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">a&nbsp;Delaware corporation</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By: <u>/s/ Justin M. Hall</u>___________<br>
Name: Justin M. Hall<br>
Title: CEO</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Landlord:</b></p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 35%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">KBSIII TOWERS AT EMERYVILLE, LLC,<br>
			a Delaware limited liability company</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; width: 20%;">&nbsp;</td>
			<td style="vertical-align: top; width: 45%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 35%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:-36pt;">By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KBS Capital Advisors, LLC,<br>
			a Delaware limited liability company<br>
			Its: Authorized Agent</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:-36pt;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; width: 20%;">&nbsp;</td>
			<td style="vertical-align: top; width: 45%;">&nbsp;</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 14%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">By:<u> </u></p>
			</td>
			<td style="vertical-align: top; width: 20%; border-bottom: 1px solid rgb(0, 0, 0);">/s/ Brent Carroll</td>
			<td style="vertical-align: top; width: 20%;">&nbsp;</td>
			<td style="vertical-align: top; width: 46%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 14%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">Name:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u> </u></p>
			</td>
			<td style="vertical-align: top; width: 20%; border-bottom: 1px solid rgb(0, 0, 0);">Brent Carroll</td>
			<td style="vertical-align: top; width: 20%;">&nbsp;</td>
			<td style="vertical-align: top; width: 46%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 14%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align: top; width: 20%; border-bottom: 1px solid rgb(0, 0, 0);">Senior Vice President</td>
			<td style="vertical-align: top; width: 20%;">&nbsp;</td>
			<td style="vertical-align: top; width: 46%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 14%; text-indent: 36pt;">Date signed</td>
			<td style="vertical-align: top; width: 20%; border-bottom: 1px solid rgb(0, 0, 0);">1/24/22</td>
			<td style="vertical-align: top; width: 20%;">&nbsp;</td>
			<td style="vertical-align: top; width: 46%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center;">PAGE&nbsp; 6</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>3
<FILENAME>ex_325549.htm
<DESCRIPTION>EXHIBIT 10.6
<TEXT>
<html><head>
	<title>ex_325549.htm</title>

	<!-- Generated by ThunderDome Portal - 1/28/2022 4:45:53 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin-bottom: 0px; margin-top: 0px; text-align: right;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.6</b></font></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FIRST AMENDMENT TO</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>EXECUTIVE EMPLOYMENT AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This First Amendment, effective as of December 31, 2021&nbsp;(the &#8220;Amendment&#8221;), to the Executive Employment Agreement dated January 31, 2020<b>, </b>by and between NovaBay Pharmaceuticals, Inc. (the &#8220;Company&#8221;) and Justin M. Hall (&#8220;Executive&#8221;) (the &#8220;Agreement&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>WHEREAS</b>, the Company and Executive desire to amend the Agreement to extend the term of the Executive&#8217;s employment with the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>NOW, THEREFORE</b>, in consideration of the foregoing recital, the mutual covenants herein contained and for other good and valuable consideration, the parties hereby agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Amendments to the Agreement</u>. Effective as of the date hereof:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 63pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section I(B) of the Agreement is hereby amended as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 27pt;">&nbsp;B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Term</u>. Executive&#8217;s employment with the Company is at-will and shall be governed by the terms of this Agreement, commencing on January 1, 2022 and continuing to and including December 31, 2023, unless this Agreement is terminated at some earlier time in accordance with the terms of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No Other Changes</u>. Except as expressly stated herein, this Amendment does not amend or otherwise modify any of the terms or conditions of the Agreement, which shall remain in full force and effect pursuant to its terms. Any terms not defined herein shall have the meaning set forth in the Agreement. To the extent applicable, each party hereby represents and warrants that its respective signatory has been and is on the date of this Amendment duly authorized by all necessary corporate action to execute this Amendment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Governing Law</u>. This Amendment shall be governed by the laws of the State of California, without regard for choice-of-law provisions. Executive consents to personal and exclusive jurisdiction and venue in the State of California.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Counterparts</u>. This Amendment may be executed in counterparts and by electronic mail, and each counterpart shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[<i>Signature Page Follows</i>]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>IN WITNESS WHEREOF</b>, the Company has caused this Agreement to be executed and Executive has hereunto set his hand, all as of January 26, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" valign="top" width="38%">
			<p style="margin-top: 0; margin-bottom: 0;"><b>NOVABAY PHARMACEUTICALS, INC.</b></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" valign="bottom" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left;" valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left" valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>Paul Freiman<font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"> </font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;">Name: Paul Freiman</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;">Title: Chairman</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 180pt;text-indent:36pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" valign="top" width="38%">
			<p style="margin-top: 0; margin-bottom: 0;"><b>EXECUTIVE</b></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" valign="bottom" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left;" valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left" valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>Justin M. Hall</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;">Name: Justin M. Hall</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex_329098.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_329098.htm</title>

	<!-- Generated by ThunderDome Portal - 1/28/2022 4:54:50 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin-bottom: 0px; text-align: right; margin-top: 0px">&nbsp;</p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font><img alt="logo01.jpg" src="logo01.jpg"></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NovaBay Pharmaceuticals Announces Changes to Its Board of Directors</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>EMERYVILLE, Calif. (January 28, 2022)</b> &#8211; <u>NovaBay<font style="font-family:Times New Roman;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font> Pharmaceuticals, Inc</u>. (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing high-quality, scientifically formulated products for the eyecare and skincare markets, announces the appointments of Audrey Kunin, M.D. and Julie Garlikov to the NovaBay Board of Directors. Dr. Kunin is a recognized leader in the skincare product industry and has served as NovaBay&#8217;s Chief Product Officer since its acquisition in November 2021 of DERMAdoctor, LLC, a company she cofounded. Ms. Garlikov brings to NovaBay more than 25 years of marketing experience, including deep expertise in health, beauty, eyecare and dermatology products.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NovaBay also announces the resignation of Zhang Xinzhou (Paul) Li as a director. His vacancy is being filled by Yongxiang (Sean) Zheng. All changes to the Board of Directors are effective immediately and result in an increase to the size of NovaBay&#8217;s Board from six to eight members.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;This is an exciting, transformational time at NovaBay with the recent addition of DERMAdoctor and our planned further expansion into the large, lucrative OTC eyecare and skincare markets. We are delighted to welcome professionals to our Board who bring highly relevant experience and records of success,&#8221; said Paul E. Freiman, Board Chairman. &#8220;In less than two months Audrey has proven her leadership skills and industry knowledge, and is instrumental to our new product strategy and the development of innovative products for both the skincare and eyecare markets. We look forward to calling upon Julie&#8217;s expertise and fresh ideas, particularly in formulating effective digital and social media strategies to create brand awareness and demand generation for our products&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;Sean has international experience in the medical device arena and was recommended to fill our Board vacancy by several of our large ex-US stockholders,&#8221; he added. &#8220;The Board would like to thank Paul for his valuable contributions over his nearly seven years of service as a director.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;We have created a new NovaBay with the acquisition of DERMAdoctor with revenues diversified across the eyecare and skincare markets and a path toward profitability,&#8221; said Justin Hall, NovaBay CEO. &#8220;With the addition of our new directors, our Board better reflects our new direction with added industry and marketing expertise that we expect will be highly valuable to our success.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Dr. Kunin has been the creative force behind all DERMAdoctor products since 1998. At DERMAdoctor, she led the formulation and development of numerous innovative skincare products. Dr. Kunin graduated from Ohio State University and received her M.D. from the Medical College of Ohio. She completed postgraduate training in dermatology at the Medical College of Virginia after serving as Chief Resident. She is a fellow of the American Academy of Dermatology and formerly served as an Assistant Clinical Instructor of Dermatology at the University of Kansas School of Medicine.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Ms. Garlikov is a classically trained consumer product goods marketer who gained her consumer experience at Procter &amp; Gamble, Johnson &amp; Johnson and PepsiCo. Since 2020 she has served as Vice President of Marketing of GRAIL, LLC, a multi-cancer early detection company. Prior to GRAIL she was Chief Marketing Officer at NewAge, Inc., a healthy products company where she led all aspects of global marketing including product development, creative, social media, digital and&nbsp;branding. She previously was Chief Marketing Officer of Shaklee Corporation and held senior marketing positions at dermatological skincare companies Rodan + Fields, Obagi Medical and Nuvesse Skin Therapies. Ms. Garlikov holds a BA from the University of California, Berkeley and an MBA from Columbia University.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div contenteditable="false" data-applyto="p" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="2" data-suffix="" data-textalign="right">&nbsp;</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Mr. Zheng brings to NovaBay more than 27 years of experience in mergers and acquisitions, fund management and the import/export business. He is CEO of Q3 Medical Devices (Shanghai) Co. Ltd., having previously held CEO and Managing Director positions at Boill Fund Management (HK) Co., Ltd. and Sprott-Zijin Mining Fund, a joint venture fund between Zijin Mining Group and Sprott Asset Management LP. Mr. Zheng is a chartered financial analyst and graduated from China&#8217;s Renmin University . He received an MBA from the University of New South Wales in 2002, and an MA of EMBA from China Europe International Business School in 2010.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>About NovaBay Pharmaceuticals, Inc: </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets. Avenova&#174; is the most prescribed antimicrobial lid and lash spray and CelleRx&#174; is a breakthrough product in the beauty category. In November 2021, NovaBay acquired DERMAdoctor, LLC, a company offering more than 30 dermatologist-developed skincare products sold through traditional domestic retailers, digital beauty channels and international distributors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NovaBay Pharmaceuticals Forward-Looking Statements</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Except for historical information herein, matters set forth in this press release may be forward looking within the meaning of the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial progress and future financial performance of NovaBay Pharmaceuticals, Inc. This release contains forward-looking statements that are based upon management&#8217;s current expectations, assumptions, estimates, projections and beliefs. These statements include, but are not limited to, statements regarding our business strategies, current product offerings, marketing efforts, and any future revenue that may result from selling such products, as well as generally the Company&#8217;s expected future financial results. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or achievements to be materially different and adverse from those expressed in or implied by the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, risks and uncertainties relating to the size of the potential market for our products, the integration of DERMAdoctor&#8217;s business into the Company&#8217;s business, the possibility that the available market for the Company&#8217;s products will not be as large as expected, the Company&#8217;s products will not be able to penetrate one or more targeted markets, and revenues will not be sufficient to meet the Company&#8217;s cash needs. Other risks relating to NovaBay&#8217;s business, including risks that could cause results to differ materially from those projected in the forward-looking statements in this press release, are detailed in NovaBay&#8217;s latest Form 10-Q/K filings and Registration Statement on Form S-1 filing with the Securities and Exchange Commission, especially under the heading &#8220;Risk Factors.&#8221; The forward-looking statements in this release speak only as of this date, and NovaBay disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><u>Socialize and Stay Informed on NovaBay</u></b><u>&#8217;</u><b><u>s Progress </u></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Like us on <u>Facebook</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Follow us on <u>Twitter</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Connect with NovaBay on <u>LinkedIn</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Visit NovaBay&#8217;s <u>Website</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><u>Avenova Purchasing Information </u></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For NovaBay Avenova purchasing information:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Please call 800-890-0329 or email sales@avenova.com.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Avenova.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><u>NovaBay Contact </u></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Justin Hall</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Chief Executive Officer and General Counsel</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">510-899-8800</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>jhall@novabay.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><u>Investor Contact </u></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">LHA Investor Relations</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Jody Cain</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">310-691-7100<br>
<u>jcain@lhai.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"># # #</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>nby-20220124.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 1/28/2022 4:52:38 AM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:nby="http://www.nby.com/20220124" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.nby.com/20220124">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nby-20220124_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nby-20220124_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nby-20220124_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.nby.com/20220124/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="nby_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>nby-20220124_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 1/28/2022 4:52:38 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.nby.com/20220124/role/statement-document-and-entity-information" xlink:href="nby-20220124.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.nby.com/20220124/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>nby-20220124_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 1/28/2022 4:52:38 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>nby-20220124_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 1/28/2022 4:52:38 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.nby.com/20220124/role/statement-document-and-entity-information" xlink:href="nby-20220124.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.nby.com/20220124/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>logo01.jpg
<TEXT>
begin 644 logo01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MX'W6786.&PT*$5:R7W]?Q/Q4_P""G_\ P5X'C<ZQ9Z1XB\4F&35K_2-"\/\
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M ,&LGPW\57CS^#/B/XO\-KR4M=5MH=8A0^@;]U(!]6)]Z]7"TL#45JU64/\
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<JM:I5FZE5MM]6=-&C3I05.E%)+H@HHHK,T/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140712721182792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">NovaBay Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Jan. 24,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-33678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">68-0454536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">2000 Powell Street, Suite 1150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Emeryville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">94608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">899-8800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NBY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001389545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>nby20220118_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nby-20220124.xsd" xlink:type="simple"/>
    <context id="d20228K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001389545</identifier>
        </entity>
        <period>
            <startDate>2022-01-24</startDate>
            <endDate>2022-01-24</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20228K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20228K">0001389545</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20228K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20228K">2022-01-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20228K">NovaBay Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20228K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20228K">001-33678</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20228K">68-0454536</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20228K">2000 Powell Street, Suite 1150</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20228K">Emeryville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20228K">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20228K">94608</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20228K">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20228K">899-8800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20228K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20228K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20228K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20228K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20228K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20228K">NBY</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20228K">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20228K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M!D \5!B'G*@W!   7A   !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R5
MF%USXC84AJ^WOT+#53L3X@\^8G: &2!)E^XNRP3:G6VG%\*601-;HI(<X-_W
MR(!-I^:8W,0?6*\>'1V]1TI_)]6KWC!FR#Y-A!XT-L9L/SJ.#C<LI?I>;IF
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MJ^BCE??1OM+'<=QWY(6MN3:*0F\SFK*JP>-",_E&Q_1 YAL*J"'+# ]IHN\
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MN&_/%6N&$!X&"RS?URR9B)@BW^+XROSA>K5D91'P<,O^']E4ZPS(:@%QV5K
ML@IXN&<ON8&"*6/B^3^O?B$+%F:0;X=*)ES)YB<4MX61X2NV1RV]WL>]>:EH
M9%-L<4A7LC+!:@1FXQ\82.GJ/F[ YZ"0IWVXH6+-KNYD:X1F/Q;87L>_V+_?
MYN6V?*UMC'X%";.Q'K&EHG+V:A3K,LHOK=S'G7@$>1[EN?Z<T'4E"BY0BU*:
MN8_[\#E,$Z!18.M36'1[\IE5!PC7@KV-UPIZL/VJ0G,N3HOVY/V5VGG1)&$Q
MJ+GW#V#-ZGB8/3X8N<T/D"MIX#B:WVX8!4^P'\#OL93F_&#/I,6_%(;_ E!+
M P04    "  &0#Q4GZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX;6S=5VUK
MVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=A['-
MH<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6,>=5
M6R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0G
MCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C$C*$
M[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,
M/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!
M6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@
M?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\
M@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T
M7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIU
MTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>\%G'
M!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%^@2O&+(=
M/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@
M/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&
MD3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?
M)=-[*CG_5U/\!%!+ P04    "  &0#Q4EXJ[',     3 @  "P   %]R96QS
M+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0
M"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#
ML%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S
M##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H
M5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    (  9 /%0ZJJ+G0 $  #P"   /
M    >&PO=V]R:V)O;VLN>&ULC5%=:\,P#/PKQC]@2<M66&D&8]U'86QE'7UW
M8J41M:U@J^W67S\E(:RPESW).HG3W7EQHK@OB?;JR[N0"MTPM_,L2U4#WJ0K
M:B'(I*;H#4L;=UEJ(QB;&@#V+IOF^2SS!H.^6XQ<ZYA=-L10,5(0L .V"*?T
M.^]:=<2$)3KD[T+W;P=:>0SH\0RVT+E6J:'3"T4\4V#C-E4DYPH]&09;B(S5
M'WC3B?PT9>H1-N6'$2&%GN5"6&-,W&_T_$8T'D&6A^[ ](2.(2X-PW.D0XMA
MU]&(B^S"1I_#6(<0Y_$_,5)=8P5+J@X> @\Y1G"=P) :;)-6P7@H]+BB[H-5
MCX$E)+4* Y7L=D[E],H.KEGD7F08YRB#N+*#\%&MA1H#V#<YD 27Y*IU5%WI
M>:;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$%     @ !D \5"0>FZ*M
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  &0#Q4)E:?WNT    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  &
M0#Q4F5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    (  9 /%08AYRH-P0  %X0   8
M  " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  &
M0#Q4GZ ;\+$"  #B#   #0              @ %Y#   >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    (  9 /%27BKL<P    !,"   +              "  54/
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (  9 /%0ZJJ+G0 $  #P"   /
M          "  3X0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  &0#Q4
M)!Z;HJT   #X 0  &@              @ &K$0  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    "  &0#Q499!YDAD!  #/ P  $P
M        @ &0$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(  #:$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="nby20220118_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nby.com/20220124/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="nby20220118_8k.htm">nby20220118_8k.htm</File>
    <File>ex_325548.htm</File>
    <File>ex_325549.htm</File>
    <File>ex_329098.htm</File>
    <File>nby-20220124.xsd</File>
    <File>nby-20220124_def.xml</File>
    <File>nby-20220124_lab.xml</File>
    <File>nby-20220124_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "nby20220118_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "nby-20220124_def.xml"
     ]
    },
    "inline": {
     "local": [
      "nby20220118_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nby-20220124_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nby-20220124_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "nby-20220124.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "nby",
   "nsuri": "http://www.nby.com/20220124",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "nby20220118_8k.htm",
      "contextRef": "d20228K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.nby.com/20220124/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "nby20220118_8k.htm",
      "contextRef": "d20228K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.nby.com/20220124/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001437749-22-001821-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-22-001821-xbrl.zip
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M\!P@0B_)"8."<_$(U*;'/:8]:E7M)T3\B9RR- '7IC/,L0GR7%FSLV0R]0!
MK%F!T^.#R%SXF)L4]XO","7HJR&V(]GCYCSY8DV-<ULC]GLJ;3[5]N& :GS.
MORR@AY2N1!/9SZY4\><=3NQ[?+"[@  W'NV(K?I/J;,7/;_X<W:%/-5\:8&<
M_G_;B\.O#0J.C .[=N >V;2IA[HQN05UZ6E7A,/>8MT1^._2KKA6>'26GI6D
M.)BDRUJOU[9_>KC+_UYL&9 ,AN8 9&XBG_F<>\Q:J]7-EP!8K8CRBL;8N 7E
M1/YPULRGM(.F7F^$<B5VYY"F'W@8"ZE</MVYPXM/+QJR-##8\!WI]A+1?5I6
M554XA[_A_LL6-[[_627NQ9%W=:7!L<YET31QS]4'B-/+1+U5_G=KN]=%H/>K
M&TY]LUE;K[])W%])XE99XK;Q\]J;Q+T@ KU?W70:ZVNUC:TWB?LK2=Q:;H];
M?Y.X%T2@]ZM;3G-CN[;:?).XOY+$K><D;N--XEX0@=ZO;CMKC<W:VIM5^9>2
MN(V<Q&V^2=P+(M#[M;JSOKU=VW[;X_Y2$K<)$K>YLMIXD[B71J#W:PUG"_:X
MN1+W#OYB-.-[A4Y<?2WZGHRB7Q8N/AS\.XV06%=S?2:R0>LO1C8H';TTUE'W
M,AVL"B^Y"4K/C@;+87 S>Q&C.>+BP]FOIPO[%ZT/'1/#:^RMP'U8OI#_\VYO
ME&HNO'GYX++3^O=RZZC;N=P1TKN1T\CR$!+05P60=L5(\=J:Z&PWGOI_U.D?
M>$[V/P_#(/'=Y>)/,VCX>%B-!JX/>"(2NN?M$^U_SDA9@8 4#]7,_]AR@ZIP
M;&XI+S 0O/K(0'"KQSF_%)#G8/!9$&.$,XJECU'%4LZ-C70Z8A(&UYKCJA11
MU9P_J7T;SL]%\ M)!:*GI@'FYF FP&3B@9+%2"8\C*G(%-5-,+T52!+D<V;R
MB3(1I;0A\&9ZS%)H;.Y&(N@!3C@ ;$+2E!PT$^1UDS!='>6"K"\)T/8 IPQM
M3DB:W(&.>2?[O)K[O);[O,XI'.GW#;'(^4!#@'E(,6M"- XL&?.S@/44PL7I
MIW( :@,%T>.B![@Q5 ,5AIPN*2-12MXHDC.?O''(ZV5X\#8*I/-"TZCXC09!
M UZ"__<PS2F:8/(34L?&Q &A]""N %,_*&D*1E$QYF=FR(_F41\3N_I>@JSE
M4"@]2&*NMC )5H<ZA,6*SNU$^9&*:A:V7"95Q$GLR$"6U["&C.^SW'4?9T6\
MVKY, /-9EGJ \"6(]"AFCJ;2L?'$(]0B76AEG FF;B7 FE&5T,N/,AU!2C'1
M'#.T-2:*(:P(B!Y/0GC40$BT-*GQE,<$5 :1 [T$Z/%2$3-KCD&E('URHO;@
M11/8/F4TN)R029,C*0<I%C)A(O+2AL?Y=+@65RN3<A<'6*B7^+!^L)4PCSI*
MQC;OHL"+8C&[!Z:4P&2AQ&&!]#XL1D:@/H)KPS"%E(TEL'&R]%& %/.Y^D T
MUR1Q]%0?RP;U&$'CU'\WX94#MQ(R,NZ Q=I5[J8JS!&CX$9=(U&KF"U-)#1\
M!ZC%'-DTCS!*>A'7&:(2U+X!'J8BOB::&4P:] EY+;5G29]E!0(ZY UF1,'0
MZL\$<Z98C'*$Q3L6[Y$A3E(T<_$(;7VM/=$.7"6N#+"-[?5&K8G+6X$IZ=L:
M+Q8 !D[NJRC"A#D8-8EA($J>@UT-%"0 $2TY-N\=4 <X,ZA+D[F^AOI_]D2N
M)V2^YG;N_']5.:]KCT[QIIQ@1O3Q&/F7LUMIZWZ%N'ITEO"B7+H'0>9/*E0F
MTXM%'<7-BKB/:B^XH9PNT%G)!']\WUROU>O(?;.50T&05NZDJ6&+NJ9JCGVX
ML0TGG4T<P4&=QLJN<#]E$\-",<%S\.""):=@#]QM M@U%9)6L1I2"5*:!5V(
M]0%#WZ32P1ZG8D4*C!("=8[!.+ESD(0]'8U**"@"4,F=.5 JDNDXC[J'I4YW
M5@X QJSNVBID$/(P:*^8(5I>;#*VHWL-#E:6H&U#MHE(QYM5!#VJ5IO9&#D9
M]2;4,2A[)N,U;(762JK P5V[C:^ +FAJS)NN, $JS@ENIEF.8\5\)I<V@D5&
M ZV832JK,(P2A]-6#%=Q]V*!2%%=:Q33-:LE#/ASW$O"B,NE4C84S+,\.W'8
M/7 CS9%,O+N&L 4NKM:7A MG5S/6#'IL/CZ,NJB78-?7F!-]'<"&8JH0C8%C
M<!"CZ16$D=WZ@/?R5V<J<&';3'\M\#*2 [;Q@)2%2Y7'"#[*,Z@Y#^MO/##;
MC:SFI<8!2 %4=:OZ"9I)B9\S<<18]4?2U_UTA9X&-C/)U;-+FH42I[L9P5W6
M7B?#!,4@JQ!,2<2G%H ' ,J,>NUS%P4D5PCS F ].G_\F:C(M&VPE/@QMI[>
M/5M/81OJ%H1 1WE;A^I=#4-4B #3@Z4*M8+5W%;XF3Z3))P$>)[B(QT\U4O(
M-DUKU[&RB\YL"9Q'44N280GFG.>E&=*@T7T=)WC6 -YQ\3!\BU]A.+@;ML&(
M&!* @\_QU,K^L3G^56JC;-FS:P"F.01I'?=@!:N-V?K^\R3&:IN*XHB2NH$!
M 5?84B25K4A>4X5FKKC&JB;0#]=H8XH^R*)&'<]'++N>LM,#5E6T\;-:(3,9
M*XQP.@.86:TY"C-TKHY8-=Z)K9Q+PN2U6]L$;)4$3Z4PVCW.E6>7Q"<[O*H<
M6O=YP4 H^X\0RCG$+GBX2A4":?TO'8+)X@(YGC)%B*/GDM.HV<PY8(W$C2^Q
M,)M-9ZM>_^H6YA)5!EGQD$.)BB+GE?(!][B!X[!XNI[KW4G=@GDS"C;8L68C
M,I46:SR9@Y]UGBC/F!THQ6R>2CQ\W@$;&[>D7Y$>^6*6O#JIB?NY]RW04 HT
M--\"#6^!AHI P_H3B].IN8NU=,NZSI1QSO/W:C)C)V"<<)L1;",21/!<5#$6
M>UG!5D[08\AM=K(30/7\=\RM;OL**WXC+- $""(8-%5U< *X5@\R!+(C=':^
MGJTU R,!*(A%GC<P=Q3@85&P4B/;[T93/21[- 8@)U%Z\LR=V6<PPA75?X E
M08LW=6QYX\:I*DSNX\JCXE#&8&M=+1]?&1,M15[:'>!Q2,SWT*#%EB#SE:9A
M4RS[MIIT:!:;18JP10H:L_ASJ S'&)L7D"K#$ #%GX8R=',V5S5;.&7,PI64
MD.8[PI+Y'-B^U+XC#%EL4QB1EA928Q>"IN2Z(&O$T$A2V2P-!C"99Z-$Q[:B
MEFS#Z6QIO&4'7%/2)^R4XF2])-(^EA-+W^S5;"GGD64.XXPN]"'DD.P(37,[
M5.TN*QP*3$D>/D_*FLBW(\J<T:NI3R?77"=S6U=$ MUK8D;KSJ)%I.6CV,V(
M/Q?,=\M&10+[)3IE5RRED*?(Z!G";H;'J(D!' $1;4P6&:#YT2*WN;B"GS4L
M(X+E'K% %-MC/&7=:"J1+\=ZIRS931WJ3BJ7=P$D%MNMJPE&.WV[#L-7[(&;
MY#4HME#$.G,%JDBEB)NYE5P[4^/-RQP3N3,OFJ5QF-"BET/%T31)L&G#S&20
M@T#:T $&'BC>44-_WBA(AJ/LFG #Q?$YX[M#*L"Z\J0Q4)2A=:PW:JQ"Q$EZ
MNA7!C<^:UN/0QUA.:0JX@1LDDJ,,?E.LHG)5[NRZH[/C0^%(I33H]Y.)I X2
M<.8.L%$E@I6[/*B<F62PX)"INHL;(]B.,+PW<;,,S[:=,&<($O2A\<-9X"C:
MR%XMVI(LKQ;7Z)2CP\28*@L<S]PO3>L8C);B V/YV9R\40M)'0)U%;('!I9C
M# &&%!B^UH$G4W_PH]@J=2NJE 8ULWME05<"S)_G#RB=_LM=16:.0U4=/QCG
MI*X6Y9*]"KSF"+)R8&&3] ADKD2!QZAR3,3:<!G%JS,9OKA?=B\*,HLL\76E
M-J?$0$P=L=A;,KQ1R8#](, MV!;TYSR-[/1.K3;@0WNFY?#D:$;.(M/=+D7Z
M+$X=/M'+PDYWK:Q5:7TP-'R96Q?[2T7G %AW2!?RBLZF2EC&_DX<7;16LHVL
MM(]IM.UY9Z#^F-6HK)4=:-:WGZ(V@?4"AX%2<*FK2,M-O=>79*]9;R6A(7_P
MAS6"MD7G<I:0DC.=F L(794Q$]L%!9_C^\K&%R/-DL8:S47[K.B--\&2+),I
M;[03"LDM$=$W> ;9DA# .2 3':;&I9(A"%76GB7O&BJ$P1>!;CQM/]<QA?$=
MZ7'B 9%5D*"-++THL-,B2I%8RSE"SD'?4I4ORP]**5*Y<2V7EO!)IG3>=IG=
MX:P["%!G#)MG=T1^V\C]QA//O]DI^-+VG\0=<[><]O06T'],F[O<49-W@)S&
MR\5_BT<Q:X!DBA-M_)ZB2)OM#6H:WI%$>#;F<D=R&\8?\^HVW2A<[$/FLMHG
M!RUJA:W&AE/?KL^)^5.$L #RW:.M;C2<YN;:G-&R&%]!\]T]Y'R'\8_!G(\)
M^>7_7]W0J-"[^HG]BY#!2D?YJY%Q;I5T2$;;9JW1_,ER@.$IW'1^A]TJNTNZ
MB)4LGI:FPT[Q-NJ[*8X,E/(ZT*X-3[E!THN=D@L"S<O$.%VP>6I4O1D5NX,]
M=&4< 4?S.,TN*&$W <1Z62MQBC2N/CO3OOSHF%&N<_R@.R:&8M7<; ?CB;4S
MT2,$^ID#3WBP+F0,,/$HP\,E-3[E^#4\EO61-HWE;%*%+X?<(UZ"@>0/L\F<
MC+5+/MAB^,YAOJ$3+?(X_'6H[>R?Y%(C2XM[0(/Q.%;":'TCB&4>Y*:IF-:K
M0@I#<=])7 >KZS2_)',\W).*%"HX3'K<CI([<TL\$)53K-IH4E\$@1>5&N!7
MI ZE!RJ%4>A^2/DW-NQ]1:9_.AKY.TR:"!OPZE9BS@[+=K:N67+:W(.*>TRZ
M F_5KU<"GQ8GV?PB.S&S%B]D^)F:BF.$Y#!+%+BKNUV^-U\I70(]"!Q1EK"P
M6SAN<-[VC4*_^&*SO@0*%(_$X;4B^23?#+:54]9CC#Z,Q=4E,>\N+GTH/QI2
M7!Q.2 G,YUA?2RD?W>$\B=*C)JDI=U"[D10.@O,S'9.&Z*8&0$R^>JF!Y%+I
M3(NE(15Y?0HSLW%:.SV^9V:(LFM2+2,)F@$%);]CYD6A0L=D*LW8IJ%Q3K]O
M-.LV&R"'<,K1H8M4H$%H>M]8KV>) ]4WULH;*-+9E&H4R3%*$[THF-13\Q,P
MZ0P>6??$LV:<O/YX^NI;//TMGEZQ3VQ]I7VBD_;F/2=_9R&D/KLMD'V$ :W%
MQI(H/TOY@;8V#L\ B.^'I6E?8L=L<1;41(-\?]SF]:[VU[D3?%IO(](R+V-#
MS&@BVQH8O83V$"7]7(=B3LU5-](K/D(]97-]NEV%N>_6BZ]#VBW!6)H68)41
M^<\(&/8G1_S: FJ5;^>:W9B?77&^!!;?_F*7V8F*8XY M2D7S!:LIK8#4+E\
M#U+E2L$&C$?,0S4)(IWSRIC8H6MR(WPU-S4"FQ3[V3Z>-@'F#.[TO%[,62C(
MG<D%I]A#@2.IWS5R[PSL,RF$[U>;J\[&^E9MO6[?*<.#)Q.*=^/=1YKPT,:3
MBG5,'YK^W&>8P8"YM^9-&IL_&A,VZE])T;;0\;#\,4C@^/OQMU:;>?$H*"3.
MR\QE:(+.S$#LME@>T=-)!.=:8V:F7J#4Y0<,]7ZS:0T_?.*'(]EC7@UPI_I(
M7]>6X"LZC)%LOE$$"W.2;!K:;!&._9V(Q&FKD2TSM6%O2DC-O__!:/P'OMCA
M.Z.V0&MV\;*1^<M"?:'46[S<6;S85_PI;\LL&W%YBS;K&5YNWV+O:OR46\!L
MEQ=SV^HVWC9#RS-..C8DW[EC@'4"QKX[D-U=K;CP+K"3DW9%"Z&O ?>]MS%T
M_94 WVXHS!NM8%E@)@5HKCT[:%N@N(#LF"0OVG28$H>AQFQ)?LW;9KW^!N"=
M %K@#I3LCQS1;HGMYL;&,P/5BF-0)/P*7TQ32_Q(><\+4O&VKPS#)TJ1 1-Q
M@@D%;_KB31Q?H#@>D&G9EF$(EH8C6A&FY)Y2V"3\"\OFS.9N=G4RTR[8-'NI
M FLLQOL5RD7MO"8.@ENQN5;?KJ\_+SE/ D"1/U0>&F\H ?7ZYMKR\\/U3=D,
MCW8Y0]\$9$2;PP/W4_"D]=\BC>(\)Y:J7FUKWKG[W,JU\(9=X*NUC?K6,_<*
M? G'M,9CWN]5??:]K"CL^)06=A2\Q.;DFB;(@HR;$A!3F9[KA>1D#56R<W*?
M7L28^G-W1)KC194L[.\B3VHOY%W4%#5SIN6UD;!<:Z\LZ[08TW-L!;IY*,P5
M\9!WC,/L:8TI2G!$[A9TO6D.\?>"&.^C1EN4?*NQW1%8>U\*W6Z:^\P^9^MX
MCVS%JO#44,).?0T4-YEF/6T2SNV+*SD9(,O83"MY=LLYR<8[;5U,P6" ^S^_
M7@\S%BA7'/!NDF\Y>2><T[.M[+%_-%/,ND^^/EN8A;](IJB&[5NQ1-;3S#)%
MH1CN*[/%C^: ?$Q7S3M]QDD\"C 0P?JV(]%]3P7N03BMJ%7#ZC(UDMX@D_J<
M!%J9I"#9B(@6P9^1R5.0=C*.4%&?&5,6PG&(-)FA,(TMU9C2\/ H6M$FTI 4
MX-4DT\"9/QP_/+YM6\8#5[:O'N_!<$B#T>T&7"0_1W;L>[@#!Q6$5098?<#J
M =0'O^&;4K24KP88]!K8OE:<HG^MLH9^QF>-]0DQ)=<Q"*QKZ/F^!D2I*,\.
M^)49XBW?XS'Y'FMO^1YO^1Y5.N2I#10R37(0!I_1L9,SW7.;0ZYRN]AWA2VT
M7/P::_*-&=%.HA&L7?PLQS#')_D9E('R7"<;F,+4:0DX3@(8 Q1\+MW3M06J
M:6/HM 4#FF8]@AU-QR%!"WO, -$68BE60.EUP%5Z# ;1@&M9L5Q7<Z>'RE@]
MURHFXW$A>3Z&]4>RSV9,H9$O;9S% /\QPT83L_?(@&ELV!R4]LI I7T59N!Y
MQ-P"F"I2IC=OODHTX@)/5XU]X!OJKA-3PO,H\-"T"\>>K>$G<\[-Z+Q(@/39
M-9^OJ^26@-0G;IKGC*5<5KWIL9.6!QJ<:,+J-,N?X!9$5 I']\:FL;0C9MLN
M9/8K%92E-G)MK[<OTC>9_D!F1+&&3-SQ)Q/ZLT"<4_K1:>!JV*EEEN1U3ZEQ
MUGPC2_M$XX!&P4K<,8UH<Z"*B2S9B86/$S'72=E',"]L,O&(NE0SQ5%O.AQE
MLV%/PZ%Y73TP"VQR:0T6CQVJ,?(=WH!M6U $34M@1<4=,&E\@_/.6B6XKG0!
M%;+=#8RVBVWW<I]2W;G426&1?7[P>7EMY;X6=]TYB\&'W6NDR_89<\40&V,7
M%CUC*II\Y+2=)*FD!&T9? +T+!Y:<:I\SE!6]"510/40$X>X#,.4/9CC<AP,
M%7>P2#,([8$8<P<M*N@PH:EZF9!NY9H\I[9RK@(U?*3 IH-(.=!,U&5:I66W
M8>#KOK@X/,KI'6,&IYW_QBEMD<'-6G(C/_L9Y<O*U8Q=6ICS?\[.Q=&OE]V/
MG4O1[?Q75YR?B>['XRN!%N6NN#K^<-;J_GK9N<(?CLY/3LX_'9]]H%__]_M"
M^GUL>C2]'VS3YTST]==KE%=9V*^6QQ]6DGE\)CX==\\Z5U?B$W!^Y_S(*6X'
MF-&<ZL&RF57L#I2U+*(.7J]11Q1F2!L6[[P$<^I+5W-V_EOKH/6[N/C8NCQM
MM3N_=H_;K9,K1QR?M6O.MYQ9\N(.E<>'EGX FU=H3*WG1>IK(-P!F-)@JJY$
M*^)?*-.^.*V)C[!SHYWZG^R?O5ZX_^X,MNZ=\GWX0Q>+U79$NW/^W/AX#3@'
MT;?V?U[XORBG\V&@\89$.V!^UY9)'.P6-FVZ,C^OL_R^O3B8I+O=ZOI/=[[6
M[DNQ9[,_SC]U+J]$JRLZIYW+WW\[/CGI4/:'0QP)TTN1*@7;93LK8,>*=SA6
M,.J_&:PY7IKS@L.[,-FL2)1XZ+-KZX]*LG@V@J:]6\ADR-L0R\:(  WU-+_;
MW*RYQW&(N?<XCG:$"0KAFY%:0TI5^G;L<S]F7B1W5>9\%-\Q^?4RV5^.UFNL
M?3<A(9& /5M0-<074%\\[.VJ"V0=%!(6ORNO;7PU3?9=B43&TM,TUW<E[AMA
M'TE8-G8?0<WO0<4KY6,K_=\P2^8B5!%UG'O%U*QLD4.5D>@G5.XW169CI;FV
MTFR^$/0]XQN73UI7W>7,OU89FG]TR/T.OU_!U[=Q9S0:/O0"=PHZ<A2/O?W_
M!U!+ P04    "  &0#Q4,K:OJ<H(  "9/0  #0   &5X7S,R-34T.2YH=&WM
M6_M3&SD2_CG\%7W>NFQ2Y0<V(<O9QE4&#&&75QEG<UM75U?RC.S1[HPT*VDP
MOK_^NC4//S )83D"Q*ERQM;H\:G[ZX=ZAG9@H[#3#CCS.QNOVE;8D'?X]7^V
M&MO;[_Y1Q;OM6MJX\0KO_ZU2@2,NN6:6^S"<PB!(I,_U@8HX7"AM60@5J-<:
M.[7&9J,![YKOMIO;6] ]A4JETXZX9> %3!MN=TN)'55V2EFK9!'?+8V4CIBM
M^-QRSPHE2^ I:;G$WI:'/ Z4Y+M2E3H;[5J*N3U4_A2,G89NN+05(_[+FU#?
MC&T+7,.(12*<-N'UGXFRK8&(N($S/H&^BIA,&UL0,]\7<MR$32%ALUH7L@5>
MHHW236")52U:,\X7BI@>"UD9*FM5A&/BZQ9D;5;%68/EU[;"0C&63=!B'%B<
MHTV(%N#FZ'Y< O9C&5Q+&0S78I3M9;8YG&O8Z5T'8B@L-E3?MVO#3KM&O? 2
M=S:^ '<>7<A']L8&'A;L:SDT<>L6?/-S+\W<FLWD5.I^7C$MF+1-270)6W-;
M\9 K7+?2K31I@)/3X7'_<H L[)T=X&< @_-46H\,H_?/WO['P?&O/>B=7IR<
M_^:P=(_ZO1Y]^Q*D&T*_"Z@%"+D2_E_;_CTQ5HRF\XNZNP)]! [8>N]0# )A
MX%!H8Z$;<>GCQY:!CT9D\U<<F $U@@/N\6C(-6S5RX#.I)Z"?V,##J]_V&DT
M-EO%:/>[WGI;!JN .O2NN9>XR7I1'*HI=8+N6'/NOOG.??W,9,+T-%]@$Q54
M!E("^C4FT;UQ.^%<PIFZ8GML"A?HN"+F<9S88R%R_5AZ59@'M*^BF,EI#L?-
M\C/)1,)I%3ZP,(0W6=<"8=%Y86<YU/QN]7L@!BK@TX=>O]>])"V4G28SD3I1
MSK3J<R,T)VTSXH#K.5,O-N/D>3L:8D2$6N %R;7^4\L G_%C(FPPO^;W(O.S
M\T_HODGPA^?]7BIZ9"Q&7B-\"O48B',!8H#F8X6!$C3W!(;[5$M18A,,_9ZZ
MXA+1& BXYND<E@F)QD;ZP\&@L+N&L5)ITQ4+$S8,^>)JZ:0QTU;P="XR2=(O
M.8>1"D,U,<WO03WU:HKC:_^'=M(IW*/)W6)A(NU:TJE";\GE4A=RC4[B:O19
M 3_&YK^L EB&L9QX9 TY$LB@+&0_.9@L :+DQV8],CSP?LL!>L/>WD\=EVDZ
M"\=O]M[FDI[Y*S'C.*F,K.7IL/S>(IZ39O%QBET4;>.G.2![?X'N _3S&:^_
MQLN3]/'(,1$8G,DCF8#"])"CC[KB6J;'G#R.9&:"0PKME=%U1?C%(Z>(*LZS
MBC2I:+@YR0T*F5 /"EG8(J07)G3@N)'G;)4AD2$W9FD=PDD0A'3)"\/$G Y=
MG.E0X&B+6B*OS3Q/:9])C\]V>@OR;Q[?'LMZ,W?2N">YD%MG"LY=X-H/F!QS
MD_/,XTAJ-%9^'6M464@G4:>>-/Z5,XGGCAA\A?N5RF9I2QX/)\)@#%4^[@.(
MDIF'R/2FB3^^( =B;CB/,DP"X049;36/,-P2#T8)_L2 BSP@OJ79-<1XHDU8
MFB()FQ+*5*&+:Z:+$3:?CUS(SF)X.G/ ,$RX4,^9)-[B$9[F1XIAGP5(51BD
MX<8E8;C7. XQ8\8HCUD^0ZP4V*>YR].<1.>B% &=,*U=!F$#I#AAQ+MQ%J8,
M:IQ9A=85H-"'E)P[8S)D>$7T*H@^$WN"FL%3?* T<LM9-.U)HND90\:*-A,K
M*FJ@_3A'[5)(\B)\::YO;C3W"+R?C[);]S2+U5[XR'E-(L@)FZ1F,EA4QJT.
M-F23@M^7-M/D/IHYTDP*5G8.3246&3%F.DTGO4 )CU?4J(*C(=;J2ABRD[D@
MX%++/ N*N39*LM35\VMTPH:Z_)YH87R1ZM[EI5PF/&?V"C#/D09?G7^]>P!F
M$"?V54+E$#)[LY(2$9ZNASRW.#\]?<S&I*?Q*? 0_8!64G@X0N#1PRF1/,I<
M[V5_9=#5WG2$C"9%URIP^VP^\!-9K+!D^-BA*$J488BR(5JS(B!G/L<MBN1P
M0#+ZNJ(H>2ON/W.FK*ID_:LM.I?.%2=X"+]@8PZ':;;:KHG.OQ\7S(( ?'$%
M7LB,V2U='.W]4LHA3(1O \HI-O]>U#FIZ)EE"UF+*]*Z)BKV+LQU..@7D\UG
M'QDBF%M@:6PPJF@UN=GH<63;Q='9Q]/9'K '5;;G+QOM0.<+7W2/>I6]?J_[
M2Z5[..CUFQC%)FQJ6C#$G(]K2I D7P#3PC";[JI!15]/A530_F'3_<-QS/MC
MK-%X_,KBK1L"^'"P6@!IZ?B>VQ^<[Y\(^<=G!5#(874*^;65Z%5YXMQ6GHKK
M;0\[QV?PZ7APUKN\!%<5.S^\616C-,ACB>'^\FD!8]V\1UTLG]$P2K_0:2J7
MR-%8S&S]LLN+TFI ?I!IO$]/,H_IR*RK":6LWBUMEH#HDCVB*7Z;F'GY[WEF
MYFG_YJ(E_,4'&/3\ZU7;:OQ"5U>Z0GWBFBHNI0OMEK8=_ZG#\K.7]*E*X6J*
M1S$/_$SHYF,6 E.S?@$;[1P%A[@;I95;V-JYSQ:HBOAK=Z_[&UQ\Z/9/N_N]
MCX/C_>[)91F.S_:KQ:.-932K$-0;3UF(>'4<> %46*G^YXEZ^UG"?D%,SV>Z
M [WNVG7[[GV=(!?[KNWT&Z/.0+NL"A/3B6;Q;BF]SB)/"F]MQX]MQPO*N2VM
M7YT@/ .#N65#MR0\WW@[>SCJWG:40=@[[Q_T^I6]\\'@_+0XQ$$]O@:C0N'?
MLO-O;6TU4UM0Y@5+0CC47.#HAUSGL_)]&0;]3"WU*1KD(Z:@9RS"91=HOZ;H
MT]G%FJ*ESH#>_FW2@T^A7QP_-_!*I:;G5J"?K5"\6E'?N<M;-.O"VK,KK!4O
M#:^+:$]L%^OP\!1@KYF^9OJZ#/4\+6%=AGHREK0N0Q7*7/R3G1=L?L_4KIZB
M^3QZT>@ED_2QC^5SKR:=="\'E=F+5BM?!'O0%[SR]YOP"_TI,XK$_4GV_P!0
M2P,$%     @ !D \5"OJOD#'$   D#L   T   !E>%\S,CDP.3@N:'1MW5MK
M<]LVUOZ\^158=[:;S$JRY&RWOD]EQT[<V(G7=MNW^^4=D(1$Q"3 $J!E]=?O
M<PY(BI(O;7:VSJR;SMBB@(.#<YYSIW=3GV?[NZF2R?Z+/^UZ[3.UKV[___7&
MUG!K<X!O=]?#PQ=_PO=_[O?%6V54*;U*1#075VEE$E6^L;D2Y[;T,A-],5K?
MV%S?&&YLB+]O?X/_AV)\)OK]_=U<>2GB5)9.^;VURD_ZFVOU4R-SM;<VL64N
M?3]17L5>6[,F8FN\,ECM5::*U!JU9^S:_HO=]<#S;F23N7!^GO%VX_M._ZJV
M1\/"[_#'B<QU-M_^ZY7.E1,?U$Q<V%R:O^X4,DFTF6X/M1&#D38[1+5H2.6R
MG&K3CZSW-M\6P^)V1WAUZ_LRTU.S+4H]3?V.J)=Y6_ :W(8.7>*G9D#<X: G
M^$E/.%7JR8Y8<"^(?="*]H]N4QUI+[:V!J/=]6A_=YU6X4>Q_^*_P.W7)G+%
MSN=2R]3DC[YZPUBXK<ZG0F8 06:G=C@:?"JF:\*5\=*#SQ;* ]>X7R;=^ZS<
M9N<^V-W(4DOCMPTA.MOIG!L#SJK<">=NTP;6] =[(P_D7)S#/'(9J\KK6&9.
MC(VQE8EQX&$JS10_O14GWHD#*\M$V(EXHTM8BRU= ,C#?-^U@=_!^1*??[1L
M/E7.Z\G\CG".SHXN?O[QY/3TJ"<.L70R$"^_EZ:2Y5QL;/8$.9M7='WQ]5>;
M&Z/1CMBM&HD^",N'6=T*Y[JJO>*-*ED?-9] RTZFC>JGBBQK>[0Q_$MG/R/X
MJ]&W?X>H0*2QVE7=]L2)B7?7JWW<YL//ET=BG,,<8@EL?CCX^55/2%$L[8 W
MS MIYK"7N'+PP-:(1-VHS!;P9$*:A%: 2*S!YZ_T+ 5__5\J?/1SF%NL@3X]
M(6(9D2GS*F-?7I0VJ6+ "L^$3Y50<Q7+4C%1=ZT-?X!>KI4'X[)%):V516&U
M\3EH.T+DN$I*-1?O*Z--3YP-W@R8S/=5II5X*\M,7]L;PC%M;H!_%\\#\:8<
M!"I".T@#S^W40,()C%<B[@A\0S1:!NMKX'D"* $==&XJ'3F:&VS#;_5Y#)1O
M=\BLM)J(\WKCQPF$ \(.!)70N(^,?ZFTTQ2.Z#AL5WF$%<#<B-D]NC@;)Y8X
M[HG3TT-26Z,G!]YB.[$4)).!.,.5VNM')?3#UMQ((+>X@8>5BXUOQ%PA3!+]
M('/2I;HM@ \%QGK@),XJBE\ @"K"5UX[12PB,F8^[8E(R8JTWE4EA(8(:^$W
MYZW.!\_0:30RA9G9%;26RF&;9(5"OO\BMRK^3YM?4UN)E^>RREZ)4TU0D2*I
ML3@0[X# &PGCC.<$QDB1["<ZRT(B]+,UTUM-E%Y>*FE>@:PRTX$89QEE/(WC
MIO/O EV0=M1D0DG/#50($TXTS#(+^ 7#54:8QB=2?*DD%%U3(S$1L558AU,F
MI<VQY)96LZL2.:/W6>J<[KXQW+E*H1_R%P9F$6LRG9[PI30NI)?0.URIQ_E"
M^M;X9MJG-3PH0@O*#AN(=$R<%6*K4A094 7=3ZH2NTJR0)P0G$2MF@S,P52S
M*D:^3(K]>'7XJ%\=B)\48R%1&2D+Y$%JIK*8\FN8ZT0YQ^PSF(B-H.99:H,_
M87\/V)3(EF\@NH[/J*$4VS)AO^*J&!;A>BPU1$PG=2((_>)H((Y+I:&57DT?
MJ8>&Z,Q U#(^,?# S@5OY6<6OLOXU#6>GSPNV+U1Y(S*VEF[5!=TY2QSS$OK
MHZ^-G<&,2%;\'-HS^**B>$*:"C<U@$KCWO$MS&,:S(-$74=!VD%WTS#XFR#S
MI<"&7#!=#AA$H%%)5PN9M=>T94;7!P<4,$F^50$-<R!K+6WA>XG8!-::"IW
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M<>.-1\?Z^(7^@A7@XK_$_3=02P,$%     @ !D \5/I'NU%Q P  'PX  !
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M">3FG)MS3WSM)+WZ-$]B](I92H!>-YJG9PV$:0@1H:/KQDO/:_=N.YT&2GE
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ME7N?;):,[:)] >&!-^$6)=U)Q"/? #!WJY7_R CXYFW\D0H"-8LGV:QNO4A
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M &PMX)>5;ZTQB6\'Q3<L^,)>2F=E\\OEY5,\V=,X^AA,4E\2'7;)9\<+CO.
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M1-UI,+/W_A]02P$"% ,4    "  &0#Q4H"M,OS\>  #5J@  #0
M    @ $     97A?,S(U-30X+FAT;5!+ 0(4 Q0    (  9 /%0RMJ^IR@@
M )D]   -              "  6H>  !E>%\S,C4U-#DN:'1M4$L! A0#%
M  @ !D \5"OJOD#'$   D#L   T              ( !7R<  &5X7S,R.3 Y
M."YH=&U02P$"% ,4    "  &0#Q4^D>[47$#   ?#@  $
M@ %1.   ;F)Y+3(P,C(P,3(T+GAS9%!+ 0(4 Q0    (  9 /%3,JE-*UP0
M .(L   4              "  ? [  !N8GDM,C R,C Q,C1?9&5F+GAM;%!+
M 0(4 Q0    (  9 /%3([B.(^04  $,\   4              "  ?E   !N
M8GDM,C R,C Q,C1?;&%B+GAM;%!+ 0(4 Q0    (  9 /%24+ >C=00  'HM
M   4              "  21'  !N8GDM,C R,C Q,C1?<')E+GAM;%!+ 0(4
M Q0    (  9 /%0KGF.:EAL  "VF   2              "  <M+  !N8GDR
D,#(R,#$Q.%\X:RYH=&U02P4&      @ " #U 0  D6<

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
